Abstract: A sea cucumber preparation and manufacturing method thereof, comprising steps as follows: put the cut and well-cleaned fresh sea cucumber or soaked sea cucumber into an airtight container; at 70˜130° C., gelatinate for 1 min˜20 h, freeze-dry till the water content is less than 10 wt %, then sequentially carry out coarse, ultra-micro and nanometer crushing till the fineness reaches 10˜1000 nm. Add water into the sea cucumber nanometer powder to carry out proteinase enzymolysis, after the enzymolysis is finished, inactivate the proteinase, separate and take the supernatant and dry to get nanometer sea cucumber extract. Evenly mix the extract with panax pseudo-ginseng saponins extract at the proportion of 99˜70%:1˜30%. The content of the sea cucumber polysaccharide in the mixture is 2.5˜8.0 wt %, the content of panax pseudo-ginseng saponins is 0.3˜21.0 wt %. The compound preparation has complementary and synergistic effects on pharmacological effect.

Abstract: The present invention relates to a kind of biodegradable polyester and its preparation method, which belongs to the field of biodegradable co-polyester product technology. The number-average molecular weight of the biodegradable polyester material under this invention is 6000-135000 g/mol, the molecular weight distribution is 1.2-6.5, and the range of crystallization temperature is 15° C.-105° C., which could overcome the disadvantages of existing technical products and can be processed into membrane materials, sheet materials and foam materials. During processing, the picking property will be dramatically changed with the appearance quality improved; after heat resistance is improved, this new type of polyester material could also be applied to the processing course with long cycles, for example, the injection processing course, and the biodegradable aliphatic/aromatic polyester materials provided by this invention has excellent mechanical properties.

Abstract: The invention includes pharmaceutically active compounds and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for treatment or prophylaxis of undesired thrombosis.